Here’s our fortnightly wrap of all the news driving ASX health stocks.

Of the ASX’s 137-odd small cap health stocks, only nine were in positive territory over the last fortnight; nine were flat and 119 saw their share prices fall.

Code Name Price $ (March 18) 2 week return % 1 year return % Market cap
TDL TBG DIAGNOSTICS LTD 0.27 938 575 $17.9M
SKN SKIN ELEMENTS LTD 0.022 83 -33 $5.8M
NSB NEUROSCIENTIFIC BIOPHARMACEU 0.18 29 0 $11.4M
FTT FACTOR THERAPEUTICS LTD 0.003 20 0 $2.1M
MDR MEDADVISOR LTD 0.45 17 61 $110.7M
VBS VECTUS BIOSYSTEMS LTD 0.58 16 31 $13.8M
GLH GLOBAL HEALTH LTD 0.14 8 -7 $5.7M
CTE CRYOSITE LTD 0.073 7 105 $3.4M
BOT BOTANIX PHARMACEUTICALS LTD 0.077 1 -28 $77.8M
RGS REGENEUS LTD 0.07 0 -30 $19.5M
VLS VITA LIFE SCIENCES LTD 0.65 0 -25 $35.5M
NXS NEXT SCIENCE LTD 2.22 0 58 $284.8M
CP1 CANNPAL ANIMAL THERAPEUTICS 0.125 0 -5 $9.8M
BPH BPH ENERGY LTD 0.001 0 0 $3.3M
RSH RESPIRI LTD 0.074 0 -13 $41.2M
UBI UNIVERSAL BIOSENSORS INC-CDI 0.15 0 -25 $25.8M
SIL SMILES INCLUSIVE LTD 0.035 0 -75 $5.1M
ALT ANALYTICA LTD 0.002 0 -50 $7.0M
NVL NATIONAL VETERINARY CARE LTD 3.59 -2 95 $241.4M
CGS COGSTATE LTD 0.35 -5 40 $59.5M
S66 STAR COMBO PHARMA LTD 0.48 -6 -22 $41.1M
PBP PROBIOTEC LTD 1.94 -6 30 $145.4M
PAB PATRYS LTD 0.014 -6 -30 $15.0M
LBT LBT INNOVATIONS LTD 0.115 -6 92 $25.9M
GSS GENETIC SIGNATURES LTD 1.03 -8 -17 $146.8M
ATH ALTERITY THERAPEUTICS LTD 0.012 -8 -76 $10.7M
LSH LIFESPOT HEALTH LTD 0.03 -9 -50 $2.6M
DXB DIMERIX LTD 0.14 -10 55 $25.4M
ONT 1300 SMILES LTD 5.5 -10 -8 $130.2M
SVA SIMAVITA LTD-CDI 0.018 -10 -10 $14.0M
RAC RACE ONCOLOGY LTD 0.295 -10 269 $30.6M
SDX SIENNA CANCER DIAGNOSTICS LT 0.027 -10 -55 $10.7M
RCE RECCE PHARMACEUTICALS LTD 0.34 -10 100 $45.4M
KZA KAZIA THERAPEUTICS LTD 0.54 -11 7 $39.3M
CYP CYNATA THERAPEUTICS LTD 0.79 -12 -55 $81.4M
ANR ANATARA LIFESCIENCES LTD 0.18 -12 -65 $9.0M
FFC FARMAFORCE LTD 0.06 -12 -33 $7.7M
PYC PYC THERAPEUTICS LTD 0.052 -13 160 $152.4M
NC6 NANOLLOSE LTD 0.04 -13 -43 $3.0M
ADR ADHERIUM LTD 0.02 -13 -33 $9.9M
EHH EAGLE HEALTH HOLDINGS LTD 0.16 -14 -38 $55.3M
PIQ PROTEOMICS INTERNATIONAL LAB 0.25 -15 -31 $23.0M
MDC MEDLAB CLINICAL LTD 0.21 -16 -46 $49.0M
ADO ANTEOTECH LTD 0.015 -16 -25 $22.5M
PAL PALLA PHARMA LTD 0.68 -17 -46 $85.0M
BXN BIOXYNE LTD 0.01 -17 -50 $6.4M
IMM IMMUTEP LTD 0.32 -18 -11 $132.4M
LCT LIVING CELL TECHNOLOGIES LTD 0.014 -18 -65 $8.0M
AHX APIAM ANIMAL HEALTH LTD 0.39 -18 -17 $45.2M
BNO BIONOMICS LTD 0.041 -18 -77 $20.7M
BD1 BARD1 LIFE SCIENCES LTD 0.023 -18 15 $31.5M
DVL DORSAVI LTD 0.017 -19 -60 $3.9M
OSL ONCOSIL MEDICAL LTD 0.11 -19 -35 $58.0M
VHT VOLPARA HEALTH TECHNOLOGIES 1.15 -20 -7 $251.3M
ALC ALCIDION GROUP LTD 0.12 -20 140 $118.9M
SUD SUDA PHARMACEUTICALS LTD 0.046 -21 -54 $6.5M
BIT BIOTRON LTD 0.097 -22 7 $68.1M
1AD ADALTA LTD 0.06 -22 -76 $10.2M
CDX CARDIEX LTD 0.018 -22 -55 $13.6M
IVX INVION LTD 0.007 -22 -50 $38.5M
PAA PHARMAUST LTD 0.07 -22 75 $21.1M
CYC CYCLOPHARM LTD 0.8 -23 -29 $62.6M
SCU STEMCELL UNITED LTD 0.01 -23 -50 $6.4M
CAJ CAPITOL HEALTH LTD 0.22 -24 7 $174.4M
HLA HEALTHIA LTD 0.91 -24 -10 $57.4M
MMJ MMJ GROUP HOLDINGS LTD 0.076 -24 -65 $17.1M
ACR ACRUX LTD 0.11 -24 -39 $18.5M
ELX ELLEX MEDICAL LASERS LTD 0.51 -24 -22 $83.3M
AVE AVECHO BIOTECHNOLOGY LTD 0.003 -25 -25 $4.7M
SDI SDI LTD 0.7 -25 -11 $83.8M
VTI VISIONEERING TECH-CDI 0.025 -26 -71 $10.9M
AZV AZURE HEALTHCARE LTD 0.07 -26 40 $19.9M
IHL IMPRESSION HEALTHCARE LTD 0.037 -26 85 $26.5M
AC8 AUSCANN GROUP HOLDINGS LTD 0.17 -26 -50 $53.9M
OCC ORTHOCELL LTD 0.25 -26 75 $46.2M
TD1 TALI DIGITAL LTD 0.017 -26 -26 $12.7M
OSX OSTEOPORE LTD 0.365 -27 83 $35.4M
NOX NOXOPHARM LTD 0.165 -27 -63 $25.9M
ZLD ZELIRA THERAPEUTICS LTD 0.032 -27 -36 $30.9M
CAN CANN GROUP LTD 0.67 -28 -60 $96.9M
NTI NEUROTECH INTERNATIONAL LTD 0.005 -29 -67 $699K
MVF MONASH IVF GROUP LTD 0.65 -29 -41 $153.3M
MEB MEDIBIO LTD 0.005 -29 -70 $5.0M
TLX TELIX PHARMACEUTICALS LTD 0.955 -29 0 $250.9M
ICS ICSGLOBAL LTD 1.7 -30 166 $17.9M
UCM USCOM LTD 0.26 -30 63 $37.4M
PXS PHARMAXIS LTD 0.067 -30 -73 $26.4M
GMV G MEDICAL INNOVATION HOLDING 0.05 -30 -81 $19.4M
IMU IMUGENE LTD 0.018 -30 -10 $79.7M
BLT BENITEC BIOPHARMA LTD 0.024 -31 -83 $7.7M
IMC IMMURON LTD 0.086 -31 -63 $15.2M
M7T MACH7 TECHNOLOGIES LTD 0.47 -31 182 $95.1M
RHT RESONANCE HEALTH LTD 0.1 -31 31 $45.3M
RHY RHYTHM BIOSCIENCES LTD 0.05 -32 -71 $5.8M
ANP ANTISENSE THERAPEUTICS LTD 0.042 -32 5 $20.0M
ZNO ZOONO GROUP LTD 1.49 -33 1142 $243.3M
OSP OSPREY MEDICAL INC-CDI 0.012 -33 -90 $5.2M
IDT IDT AUSTRALIA LTD 0.09 -33 -36 $21.3M
MXC MGC PHARMACEUTICALS LTD 0.018 -33 -55 $25.2M
RNO RHINOMED LTD 0.1 -33 -47 $16.9M
PCK PAINCHEK LTD 0.075 -33 88 $72.5M
SOM SOMNOMED LTD 2 -33 8 $125.6M
NYR NYRADA INC-CDI 0.12 -33 -50 $13.3M
CDY CELLMID LTD 0.1 -33 -60 $9.7M
IBX IMAGION BIOSYSTEMS LTD 0.016 -33 -46 $8.7M
PGC PARAGON CARE LTD 0.15 -33 -66 $50.7M
1ST 1ST GROUP LTD 0.026 -33 -60 $11.0M
ACW ACTINOGEN MEDICAL LTD 0.017 -34 -70 $17.9M
ATX AMPLIA THERAPEUTICS LTD 0.05 -35 -62 $3.3M
MEM MEMPHASYS LTD 0.038 -36 90 $28.7M
IPD IMPEDIMED LTD 0.056 -36 -75 $33.7M
CPH CRESO PHARMA LTD 0.056 -36 -84 $11.6M
THC THC GLOBAL GROUP LTD 0.22 -37 -60 $31.0M
PSQ PACIFIC SMILES GROUP LTD 1.11 -37 -7 $168.7M
ESE ESENSE-LAB LTD-CDI 0.005 -38 -74 $948K
OIL OPTISCAN IMAGING LTD 0.015 -38 -70 $7.2M
AGH ALTHEA GROUP HOLDINGS LTD 0.19 -39 -48 $43.2M
NEU NEUREN PHARMACEUTICALS LTD 1.17 -39 0 $120.7M
APH AUSTRALIAN PRIMARY HEMP LTD 0.08 -40 -50 $5.6M
CMP COMPUMEDICS LTD 0.4 -40 14 $70.9M
AVH AVITA MEDICAL LTD 0.35 -41 100 $750.6M
PNV POLYNOVO LTD 1.45 -42 100 $998.2M
AMT ALLEGRA ORTHOPAEDICS LTD 0.15 -42 25 $14.9M
OVN OVENTUS MEDICAL LTD 0.3 -44 4 $39.2M
OPT OPTHEA LTD 1.8 -45 128 $484.5M
MVP MEDICAL DEVELOPMENTS INTERNA 4.78 -46 9 $324.1M
JHC JAPARA HEALTHCARE LTD 0.49 -47 -66 $133.6M
HCT HOLISTA COLLTECH LTD 0.09 -47 9 $24.2M
EXL ELIXINOL GLOBAL LTD 0.24 -49 -92 $32.4M
GTG GENETIC TECHNOLOGIES LTD 0.004 -50 -75 $16.3M
RAP RESAPP HEALTH LTD 0.081 -56 -11 $58.8M
ONE ONEVIEW HEALTHCARE PLC-CDI 0.05 -57 -87 $8.8M
PAR PARADIGM BIOPHARMACEUTICALS 1.26 -58 -17 $249.3M
JHL JAYEX HEALTHCARE LTD 0.013 -68 -66 $2.3M
PTX PRESCIENT THERAPEUTICS LTD 0.029 -69 -55 $10.7M
BWX BWX LTD 2.8 -73 20 $345.4M
MX1 MICRO-X LTD 0.14 -84 -44 $36.3M

Interestingly, all but one of the companies that have survived the market rout were not selling hand sanitiser.

TBG Diagnostics (ASX:TDL) got a COVID-19 testing kit approved for sale in Europe — although the news was out before it could go into a trading halt on Tuesday.

Testing kits are in short supply around the world.

Skin Elements (ASX:SKN) surged in the polls over the last fortnight after quietly dropping news of a new product in its half-year report. You guessed it, it’s hand sanitiser.

The only issue, for the punters who quickly jumped on the stock hoping for another Zoono (ASX:ZNO) (a company that went from $14m last year to $250m and is doing $150,000 in sales online a day now), is that there is no information available about Invisi Shield, when it’s going to be ready for sale, or where.

The only information that has been released is online in the half-year report confirming a development program and that it had been brought forward for “immediate release”.

The ASX pinged Skin Elements for its stock surge and the company promised to give investors a little more to go on. It is yet to do so.

Neuroscientific Biopharmaceuticals (ASX:NSB) proved that good results can trump a crisis.

A preclinical study into its lead drug candidate, EmtinB, for Multiple Sclerosis had a significant positive effect on the proliferation of cells that delay damage to the protective sheath over nerves.

MS causes damage to the protective sheath, myelin, that covers nerve fibers, disrupting communication between the brain and the rest of the body. EmtinB helped to grow more of the support cells of the central nervous system called oligodendrocytes, which create the myelin sheath that surrounds the nerve fibers.

The study indicated a very significant effect on remyelination and increased the total number of cells by up to five times after five days.

READ: Dementia sufferers in Australia will hit 1 million, can these small caps come up with a treatment?

Factor Therapeutics (ASX:FTT), the company that collapsed after phase two trials into a wound care product failed in 2018, was a surprise market beater.

Investors have been getting antsy over the long 18-month wait but the board has not rushed into anything.

It has been carefully sifting through new opportunities for the company to buy and says it’s “on the final stretch of due diligence” for three, with one in particular close to a final deal.

Blood banker Cryosite (ASX:CTE) was in the black because former star stockbroker, and its former chairman, Andrew Kroger was buying up large amounts of stock.

The now-non executive director lifted his ownership from 38 per cent to 40 per cent.